1. Colonel Bruton's kinase defined the molecular basis of X-linked agammaglobulinemia, the first primary immunodeficiency;Khan;J Immunol,2012
2. Subcutaneous immunoglobulin replacement therapy: ensuring success;Younger;J Infus Nurs,2015
3. New immune globulin product;FDA Consumer,2006
4. Guidance for industry: safety, efficacy, and pharmacokinetic studies to support marketing of immune globulin intravenous (human) as replacement therapy for primary humoral immunodeficiency,2008
5. In focus: subcutaneous immunoglobulin (SCIG);Francisco,2015